Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Revenue

Balaxi Pharmaceuticals had revenue of 561.75M INR in the quarter ending September 30, 2025, a decrease of -27.41%. This brings the company's revenue in the last twelve months to 2.76B, up 4.88% year-over-year. In the fiscal year ending March 31, 2025, Balaxi Pharmaceuticals had annual revenue of 2.93B with 21.25% growth.

• Revenue (ttm): 2.76B
• Revenue Growth: +4.88%
• P/S Ratio: 0.49
• Revenue / Employee: 4.61M
• Employees: 600
• Market Cap: 1.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.93B	512.67M	21.25%
Mar 31, 2024	2.41B	-951.38M	-28.28%
Mar 31, 2023	3.36B	570.45M	20.42%
Mar 31, 2022	2.79B	480.55M	20.77%
Mar 31, 2021	2.31B	1.86B	406.95%